Mersana Therapeutics (MRSN) Earnings
|
Expand Research on MRSN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -973.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/14/25  |
Q325 | -$1.51 | -$0.14 | -$1.37 | $11M | $6.35M | N/A |  | | Details | |
| 11/11/25 |
Q325 | N/A | -$0.14 | N/A | N/A | $6.35M | N/A | N/A | N/A | ||
| 8/13/25 | Q225 | -$4.87 | -$0.16 | -$4.71 | $3.06M | $6.25M | N/A | | | Details | |
| 5/15/25 | Q125 | -$0.19 | -$0.19 | $0.00 | $2.75M | $6.05M | N/A | | | Details | |
| 3/3/25 | Q424 | -$0.11 | -$0.15 | +$0.04 | $16.36M | $7.38M | N/A | | | Details | |
| 11/13/24 | Q324 | -$0.35 | -$0.17 | -$0.18 | $7.69M | $7.53M | N/A | | | Details | |
| 11/6/24 |
Q324 | N/A | -$0.17 | N/A | N/A | $7.53M | N/A | N/A | N/A | ||
| 11/5/24 | Q324 | N/A | -$0.17 | N/A | N/A | $7.53M | N/A | N/A | N/A |
